Effects of metabolic risk factors on production of plasminogen activator inhibitor-1 and adiponectin by adipocytes

Circ J. 2008 May;72(5):844-6. doi: 10.1253/circj.72.844.

Abstract

Background: Type 1 plasminogen activator inhibitor (PAI-1) and adiponectin are produced by adipocytes and are important in the progression of coronary artery disease (CAD).

Methods and results: Different concentrations of glucose, insulin and 1% triglycerides were used to assay PAI-1 and adiponectin production from cultured adipocytes. Triglycerides induced the highest PAI-1 production with 16.5 mmol/L glucose and 50 nmol/L insulin. In contrast, glucose and insulin decreased adiponectin production in a dose-dependent manner irrespective of triglycerides.

Conclusion: The metabolic syndrome risk factors alter PAI-1 and adiponectin production by adipocytes, in the presence or absence of triglycerides, which might play a role in the development of CAD.

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / cytology
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Adiponectin / metabolism
  • Animals
  • Dose-Response Relationship, Drug
  • Glucose / pharmacology*
  • Hypoglycemic Agents / pharmacology
  • Insulin / pharmacology
  • Insulin Resistance
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / metabolism*
  • Mice
  • Risk Factors
  • Serpin E2
  • Serpins / metabolism*
  • Triglycerides / pharmacology

Substances

  • Adiponectin
  • Adipoq protein, mouse
  • Hypoglycemic Agents
  • Insulin
  • Serpin E2
  • Serpine2 protein, mouse
  • Serpins
  • Triglycerides
  • Glucose